Atlas Trials

Institut fuer Frauengesundheit

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Institut fuer Frauengesundheit

RecordFirmDate
IMPLEMENTING PATIENTS' COMPETENCE IN ORAL EBC THERAPY PERSISTENCE (NCT07521202)Institut fuer Frauengesundheit2026-06-01
Patient Relevant Outcomes Improvement Program in High Risk Hormone Receptor Positive (HR+) Breast Cancer (NCT07531693)Institut fuer Frauengesundheit2026-02-19
Evaluating the Effectiveness of Typology-based Coaching on Patients' Therapy Management (NCT07708571)Institut fuer Frauengesundheit2025-11-04
Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients (NCT05452213)Institut fuer Frauengesundheit2022-10-12
Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDO (NCT05033756)Institut fuer Frauengesundheit2022-07-30
Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON) (NCT05036005)Institut fuer Frauengesundheit2021-07-11
Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer (NCT05033769)Institut fuer Frauengesundheit2021-03-11
Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC (NCT03289819)Institut fuer Frauengesundheit2018-03-23

Track Institut fuer Frauengesundheit automatically

Every clearance here is in the API, with alerts when new ones post.